tradingkey.logo
tradingkey.logo
Search

Eterna Therapeutics Inc

ERNA
Add to Watchlist
3.280USD
-0.190-5.48%
Close 07-31 16:00ETQuotes delayed by 15 min
152.98KMarket Cap
LossP/E TTM

ERNA Financials

See Eterna Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Eterna Therapeutics Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-173.80/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
-100.00%
EPS(YoY)
-55.89
-14.13%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-7438.03%-173.80
91.89%-0.18
99.80%-0.15
96.04%-0.61
87.49%-2.31
86.79%-2.26
-375.83%-73.76
-20.18%-15.35
-16.31%-18.43
7.90%-17.07
---15.50
---12.77
---15.85
---18.54
----
----
----
----
----
----
Revenue
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-94.12%1.00K
854.90%487.00K
--47.00K
--47.00K
--17.00K
--51.00K
----
----
----
----
----
----
----
----
----
Net Profit
32.87%-5.51M
73.82%-1.51M
95.34%-1.24M
43.16%-3.15M
-23.39%-8.20M
6.40%-5.77M
-375.84%-26.60M
-22.61%-5.54M
-22.73%-6.65M
-37.00%-6.16M
23.58%-5.59M
-32.59%-4.52M
42.23%-5.42M
48.37%-4.50M
91.50%-7.32M
66.25%-3.41M
47.04%-9.38M
-3013.12%-8.71M
-5710.62%-86.06M
-396.95%-10.09M
Net Margin
----
----
----
----
----
-1491.14%-575900.00%
50.17%-5462.83%
---11763.83%
---14142.55%
---36194.12%
---10962.75%
----
----
----
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
134.69%100.00%
183.02%112.32%
---102.13%
---29.79%
---288.24%
---135.29%
----
----
----
----
----
----
----
----
----
Debt to assets ratio
-94.67%2.37%
--12.86%
----
----
151.48%44.48%
-100.00%0.00%
4334.07%432.39%
358.73%20.33%
6.11%17.69%
22.38%16.24%
--9.75%
--4.43%
--16.67%
--13.27%
----
----
----
----
----
----
Revenue
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-94.12%1.00K
854.90%487.00K
--47.00K
--47.00K
--17.00K
--51.00K
----
----
----
----
----
----
----
----
----
Operating profit
-29.89%-3.55M
22.36%-2.09M
48.03%-1.99M
49.28%-2.50M
52.83%-2.73M
53.22%-2.70M
30.34%-3.83M
-20.59%-4.93M
-8.86%-5.79M
-21.70%-5.76M
33.71%-5.50M
42.55%-4.09M
15.57%-5.32M
44.50%-4.74M
-45.05%-8.30M
28.91%-7.12M
-99.48%-6.30M
-1072.37%-8.53M
-303.73%-5.72M
-553.60%-10.01M
Net Profit
32.87%-5.51M
73.82%-1.51M
95.34%-1.24M
43.16%-3.15M
-23.39%-8.20M
6.40%-5.77M
-375.84%-26.60M
-22.61%-5.54M
-22.73%-6.65M
-37.00%-6.16M
23.58%-5.59M
-32.59%-4.52M
42.23%-5.42M
48.37%-4.50M
91.50%-7.32M
66.25%-3.41M
47.04%-9.38M
-3013.12%-8.71M
-5710.62%-86.06M
-396.95%-10.09M
Current assets
352.10%10.00M
33.21%3.13M
-28.56%3.38M
33.74%4.79M
-64.13%2.21M
-75.50%2.35M
-32.73%4.73M
-7.92%3.58M
-5.39%6.16M
-29.84%9.60M
-55.65%7.03M
-82.25%3.89M
-74.08%6.51M
-27.10%13.68M
-38.46%15.85M
-57.79%21.93M
188.46%25.14M
988.52%18.77M
822.25%25.76M
1170.27%51.94M
Total current liabilities
-66.88%3.46M
5.96%3.11M
-78.46%2.14M
-72.39%2.65M
34.37%10.44M
-55.30%2.94M
3.39%9.95M
33.98%9.60M
43.69%7.77M
-14.12%6.57M
28.91%9.63M
0.66%7.17M
46.74%5.41M
108.16%7.65M
63.73%7.47M
-7.37%7.12M
-5.59%3.68M
55.81%3.68M
55.65%4.56M
140.52%7.68M
Total assets
108.40%10.54M
10.72%5.83M
-20.03%6.17M
-83.69%7.58M
-89.81%5.06M
-89.28%5.27M
-85.23%7.72M
-1.00%46.49M
228.68%49.66M
120.53%49.13M
149.68%52.25M
74.54%46.95M
-57.29%15.11M
-29.33%22.28M
-46.88%20.93M
-58.43%26.90M
70.91%35.38M
741.79%31.52M
679.47%39.39M
853.01%64.71M
Total liabilities
-66.54%3.68M
-3.78%3.43M
-95.10%2.60M
-94.29%3.14M
-79.26%11.01M
-92.39%3.57M
9.09%53.11M
27.67%55.01M
586.71%53.07M
361.06%46.90M
301.93%48.69M
255.42%43.09M
-57.22%7.73M
68.91%10.17M
-54.04%12.11M
-58.94%12.12M
-28.08%18.07M
108.09%6.02M
478.07%26.35M
507.67%29.53M
Total equity
215.28%6.86M
41.15%2.40M
107.86%3.57M
152.12%4.44M
-74.38%-5.95M
-23.82%1.70M
-1374.37%-45.39M
-320.54%-8.53M
-146.23%-3.41M
-81.56%2.23M
-59.58%3.56M
-73.84%3.87M
-57.37%7.38M
-52.53%12.11M
-32.42%8.81M
-57.99%14.78M
491.54%17.31M
2896.83%25.50M
2534.40%13.04M
1722.00%35.18M
Net operating income
-9.64%-2.26M
67.62%-1.15M
79.76%-1.27M
-12.08%-2.53M
44.89%-2.06M
23.94%-3.54M
-7.88%-6.29M
41.66%-2.26M
38.06%-3.75M
14.24%-4.66M
4.74%-5.83M
3.03%-3.87M
-11.36%-6.05M
20.43%-5.43M
4.78%-6.12M
41.32%-3.99M
-58.37%-5.43M
-1012.44%-6.83M
-673.84%-6.42M
-429.56%-6.80M
Net investment
---2.00K
---15.00K
-15.79%-22.00K
100.00%0.00
100.00%0.00
100.00%0.00
---19.00K
---249.00K
---97.00K
-114.73%-19.00K
100.00%0.00
100.00%0.00
100.00%0.00
187.52%129.00K
99.81%-43.00K
-18569.53%-87.00K
-117.27%-46.00K
-112.77%-147.39K
-51855.61%-22.86M
95.34%-466.00
Net financing
324.09%9.56M
-100.00%0.00
-99.33%26.00K
22504.55%4.93M
62.74%2.25M
-86.89%1.01M
-54.48%3.89M
-107.05%-22.00K
--1.39M
1.46%7.70M
142233.33%8.54M
2500.00%312.00K
-100.00%0.00
1913.81%7.59M
-99.83%6.00K
-100.03%-13.00K
20.62%11.99M
71.60%-418.62K
2314.14%3.50M
3841.56%48.56M

FAQs

What are the current assets of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its current assets were 3.13M, with a year-on-year change of 33.21.

What are the total assets of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its total assets of Eterna Therapeutics Inc were 5.83M, with a year-on-year change of 10.72.

What are the total liabilities of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its total liabilities of Eterna Therapeutics Inc were 3.43M, with a year-on-year change of -3.78.

What is the total equity of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its total equity of Eterna Therapeutics Inc was 2.40M, with a year-on-year change of 41.15.

What is the net operating income of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its net operating income of Eterna Therapeutics Inc was -9.32M, with a year-on-year change of 45.98.

What is the net investment of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its net investment of Eterna Therapeutics Inc was -37.00K, with a year-on-year change of 89.86.

What is the net financing of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its net financing of Eterna Therapeutics Inc was 7.21M, with a year-on-year change of 15.16.

What is the Earnings Per Share (EPS) of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -55.89, with a year-on-year change of -14.13.

What is the net income of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its net income was -14.10M, with a year-on-year change of 68.35.

What is the Return on Equity (ROE) of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -687.80, with a year-on-year change of 69.65.

What is the Return on Assets (ROA) of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -253.70, with a year-on-year change of -54.94.

What is the operating profit of Eterna Therapeutics Inc?

According to Eterna Therapeutics Inc's FY2025 earnings report, its operating profit was -9.32M, with a year-on-year change of 45.98.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.